520386 Launching Clinical Antisense Oligonucleotide Manufacturing Capability in a Biologics Company

Sheron Branham and Jesse Faber, Biogen, RTP, NC
See more of this Session: Risk Reduction in - and Implementation of - Process & Technology Development
See more of this Group/Topical: Process Development Division